Biocair, the global specialist for clinical research logistics, will once again be collaborating with the South African Clinical Research Association (SACRA) for their workshop on 14th June 2019 in Cape Town.
Biocair partners with the South African Clinical Research Association
SACRA is a non-profit organisation representing the clinical research industry in South Africa and aims to establish and maintain contact between clinical research and other related research personnel employed in the pharmaceutical industry. Speaking about Biocair’s relationship with SACRA, Leonard Lazarus, Africa Regional Director at Biocair, comments that “for several years now Biocair has participated in the regional workshops organised by SACRA. These workshops provide the ideal platform to share best practices for clinical research logistics, including cold chain management, customs clearance and packaging.
Biocair’s offices in South Africa cover Johannesburg, Cape Town and Durban and benefit from an extensive network of qualified agents throughout the African continent”, Lazarus continues. With this committed investment in South Africa, Biocair’s team of industry experts in clinical trials and medical research logistics has enabled the company to become the specialist courier of choice for the life sciences industry on the African continent.
Biocair is a specialist courier with over 30 years of dedicated experience in the pharmaceutical, biotechnology and life science sectors. The company has built up a unique, client-centric approach by employing scientists in front-line logistics positions and assembling a team of best-in-class industry experts in quality, cold chain and regulatory compliance amongst others. Biocair focuses on providing the most comprehensive service options available whilst delivering flexible, tailored, cost effective logistics solutions to all clients.
Biocair operates across Europe, Africa, Asia and the Americas.
Biocair is the global specialist courier with over 30 years of dedicated experience in the pharmaceutical, biotechnology and life science sectors